Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-12-17Metabolic Effects of Newer Antipsychotics in Older Patients
-
CLINICAL_TRIALS study record update · 2018-12-14Emotional Response in Psychiatric and Control Participants
-
CLINICAL_TRIALS study record update · 2018-12-14A Randomized Double-blind Trial of Aripiprazole and Risperidone in Schizophrenia: An Evaluation of Neuroimaging, Neuropsychological, and Pharmacogenomic Markers of Differential Treatment Response
-
CLINICAL_TRIALS study record update · 2018-12-13Effects of Oxytocin Nasal Spray on Social Affiliation
-
CLINICAL_TRIALS study record update · 2018-12-12Electronic Decision Support Systems for Smokers With Severe Mental Illness
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-12-10Clinical Trial of Dipyridamole in Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-12-05A Molecular Approach to Treat Cognition in Schizophrenia: Ca2+ Channel Blockade
-
CLINICAL_TRIALS study record update · 2018-11-30Predictive Coding Abnormalities in Psychosis: EEG and fMRI
-
CLINICAL_TRIALS study record update · 2018-11-28Transcranial Alternating Current Stimulation (tACS) for Cognitive Impairments in Patients With Schizophrenia: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-11-26A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
-
CLINICAL_TRIALS study record update · 2018-11-20Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
-
CLINICAL_TRIALS study record update · 2018-11-20Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato™ Loxapine for Inhalation in Normal, Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2018-11-16A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-11-16Citalopram in First Episode Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-11-14A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-11-14Remote Cognitive Remediation for Psychosis
-
CLINICAL_TRIALS study record update · 2018-11-08Safety and Tolerability of Initiating Aripiprazole Lauroxil in Subjects With Schizophrenia Who Are Inadequately Treated With Paliperidone Palmitate or Risperidone Long Acting Injection
-
CLINICAL_TRIALS study record update · 2018-11-06Diabetes Screening, Risk Management, and Disease Management in a High-Risk Mental Health Population.
-
CLINICAL_TRIALS study record update · 2018-11-06Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project
-
CLINICAL_TRIALS study record update · 2018-11-05Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
-
CLINICAL_TRIALS study record update · 2018-10-29A Double-Blind, Placebo and Active-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-10-29Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-10-26A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
-
CLINICAL_TRIALS study record update · 2018-10-24Effects of Pilates-based Exercises on Functional Capacity and Mental Health in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2018-10-23A Phase 2A, Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Primary Pharmacodynamic Markers of Efficacy of 60mg, 90mg, and 120mg of Risperidone in RBP-7000 Subcutaneous Injections in Subjects With Clinically Stable Schizophrenia